InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Kolaja Carey OConnor. Director active across 1 company, notably Revance Therapeutics, Inc.. In total, 6 disclosures have been logged. History available since 5 May 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kolaja Carey OConnor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
16,561 股@ US$3.6558.6% 占其流量Common StockSEC:0000950170-25-015353:0
15,000 股0Common StockSEC:0001479290-24-000087:0
2,500 股@ US$18.1241.4% 占其流量Common StockSEC:0001479290-23-000080:0
3,534 股0Common StockSEC:0001479290-23-000061:0
6,059 股0Common StockSEC:0001479290-22-000062:0
674 股0Common StockSEC:0001479290-21-000110:0
6 条申报中的 6 条
About Kolaja Carey OConnor
Kolaja Carey OConnor is a declarant linked to Revance Therapeutics, Inc., where he is a Director. The record shows 7 filings in total, and the most recent filings available cover the period from 2021-05-07 to 2025-02-06, with the modal transaction nature shown as Attribution.
